Christian Rolfo
Overview
Explore the profile of Christian Rolfo including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
322
Citations
10230
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ernst S, Aldea M, von der Thusen J, de Langen A, Smit E, Paats M, et al.
Nat Rev Clin Oncol
. 2025 Mar;
PMID: 40087401
Advances in targeted therapies for patients with non-small-cell lung cancer have substantially improved the outcomes of those with actionable alterations in certain oncogenic driver genes. However, acquired resistance to these...
2.
Denninghoff V, Garrido-Navas M, Molina-Vallejo M, Garcia-Diaz A, Perez-Villares J, Colmenero-Ruiz M, et al.
J Liq Biopsy
. 2025 Mar;
2:100005.
PMID: 40028486
Liquid biopsy (LB) is a minimally invasive procedure that detects biomarkers in body fluids for real-time monitoring of patients. This study developed a new LB approach to analyze Circulating Epithelial...
3.
4.
Chowdhury S, Hong F, Rolfo C, Li Z, He K, Wesolowski R, et al.
Biology (Basel)
. 2025 Feb;
14(2).
PMID: 40001982
Canopy FGF signaling regulator 2 (CNPY2) has emerged as a crucial player in cancer development by promoting cell proliferation, tissue repair, and angiogenesis. This review synthesizes the current understanding of...
5.
Fusco N, Jantus-Lewintre E, Serrano M, Gandara D, Malapelle U, Rolfo C
Crit Rev Oncol Hematol
. 2025 Jan;
104619.
PMID: 39824370
Liquid biopsy (LB) has revolutionized molecular pathology, offering non-invasive insights into tumor biology. However, widespread adoption is hindered by a lack of standardized protocols, requiring robust quality control and harmonized...
6.
Rolfo C, Greillier L, Veillon R, Badin F, Ghiringhelli F, Isambert N, et al.
JTO Clin Res Rep
. 2024 Dec;
6(1):100748.
PMID: 39717667
Introduction: In a phase 1 study, bintrafusp alfa was found to have an encouraging clinical activity in patients with previously treated advanced NSCLC. This study evaluated the safety and efficacy...
7.
Ruglioni M, Petrini I, Crucitta S, Sbrana A, Luculli G, Sadeghi Gol L, et al.
Transl Oncol
. 2024 Dec;
52:102228.
PMID: 39709717
Background: Circulating tumor DNA (ctDNA) revolutionized the molecular diagnostics of lung cancer by enabling non-invasive, sensitive identification of actionable mutations. However, ctDNA analysis may be challenging due to tumor shedding...
8.
de Miguel-Perez D, Arroyo-Hernandez M, La Salvia S, Gunasekaran M, Pickering E, Avila S, et al.
J Extracell Vesicles
. 2024 Nov;
13(11):e70001.
PMID: 39558820
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes coronavirus disease 2019 (COVID-19) and has been related to more than 7 million deaths globally since 2019. The association of high...
9.
Pisapia P, Russo A, De Luca C, Pepe F, Drago F, Rolfo C, et al.
Lung Cancer
. 2024 Nov;
198:108002.
PMID: 39509773
Introduction: Identifying mutations in the epidermal growth factor receptor (EGFR) gene is crucial for individualized treatment of non-small cell lung cancer (NSCLC) patients. Accordingly, several methodologies and instruments are now...
10.
Rolfo C, Russo A
Cancer Res
. 2024 Oct;
84(19):3128-3129.
PMID: 39350663
Colorectal cancer is associated with substantial morbidity and mortality worldwide. Detection of early colorectal cancer is possible through approved screening tests but overall adherence is quite low. Implementation of effective...